Wednesday, June 17, 2009

Heparin Ingredients collected from unregulated farms, FDA claims

Up until February, 2008 Baxter Healthcare Corporation controlled about half of the heparin supply for the US, which totaled about 100,000 vials a day. After receiving hundreds of reports (including some from 2007) that patients experienced allergic reactions to the drug, Baxter recalled nine lots of its multi-dose heparin, but continued to make single-dose vials. Baxter's rationale was that, if all of its heparin was recalled, it would create a market shortage thereby creating more risk to patients relying on the drug--even though other companies produced the drug.

In the beginning of February, the Federal Drug and Administration Agency (FDA) linked four deaths to heparin but by the end of the month, the death toll rose to 28. Baxter halted production of all its product.

Another heparin company is Braun Medical Inc., a supplier of heparin in Canada. On March 21, in conjunction with Health Canada, the FDA announced that Braun recalled 23 lots (each lot contained 25,000 units) of its tainted heparin products that were distributed to the US, Canada and Australia.

Marc Breakstone and Ronald Gluck cast doubt on Massachusetts Medical Society claims regarding defensive medicine.

Marc Breakstone, Boston Personal Injury Lawyer and Ronald Gluck, Boston Medical Malpractice Attorney of the Massachusetts Law Firm Breakstone, White & Gluck have publically cast doubt on Massachusetts Medical Society claims regarding defensive medicine.

The Massachusetts Medical Society has suggested that "defensive medicine" is significantly increasing health care costs in Massachusetts. The MMS claims doctors are ordering more than a billion dollars yearly for unnecessary tests due to concern for medical malpractice. As Marc Breakstone, Massachusetts Personal Injury Lawyer of Breakstone, White & Gluck told the Boston Globe, managed care reduces the likelihood of wasteful and unnecessary medical spending. Ronald Gluck explained to the National Law Journal that several questions have risen concerning the reliability of the data.

About Marc Breakstone:

Marc L. Breakstone is a principal at Breakstone, White & Gluck and concentrates in Personal Injury, Wrongful Death, product liability and professional liability litigation, for plaintiffs. He received his BA degree from the University of Michigan (1981) and his Juris Doctor from Northeastern University School of Law (1986). He is a member of the American Association for Justice (AAJ, formerly ATLA), the Massachusetts Academy of Trial Attorneys (MATA) where is on the Board of Governors, and the Massachusetts Bar Association.

About Ronald Gluck:

Ronald E. Gluck is a principal Boston Personal Injury Lawyer at Breakstone, White & Gluck and concentrates in Personal Injury and professional liability litigation, primarily for plaintiffs. Ron is a 1977 Cum Laude graduate of Boston College. He is a 1980 graduate of Case Western Reserve University Law School. Ron has specialized in personal injury litigation since 1980, and represents plaintiffs in State and Federal Court. Ron has practiced before the bar in New York and in Massachusetts. He is a member of the American Association for Justice (AAJ, formerly ATLA), the Massachusetts Academy of Trial Attorneys (MATA) where he is a board member, and the Massachusetts Bar Association.